Can-Fite BioPharma Ltd. logo

Can-Fite BioPharma Ltd.

CANF | AMEX
Chart Builder DCF Calculator
$2.22
-$0.02 (-0.89%)
At close: Sep 21, 2026, 4:00 PM ET
$2.26
+$0.04 (+1.74%)
Pre-market: Sep 22, 2026, 5:28 AM ET
Fiscal Quarter
Period Ending
Q2 2025
Jun 29, 2025
Q1 2025
Mar 30, 2025
Q4 2024
Dec 30, 2024
Q3 2024
Sep 29, 2024
Q2 2024
Jun 29, 2024
Q1 2024
Mar 30, 2024
Q4 2023
Dec 30, 2023
Q3 2023
Sep 29, 2023
Q2 2023
Jun 29, 2023
Q1 2023
Mar 30, 2023
Q4 2022
Dec 30, 2022
Q3 2022
Sep 29, 2022
Q2 2022
Jun 29, 2022
Q1 2022
Mar 30, 2022
Q4 2021
Dec 30, 2021
Q3 2021
Sep 29, 2021
Q2 2021
Jun 29, 2021
Q1 2021
Mar 30, 2021
Q4 2020
Dec 30, 2020
Q3 2020
Sep 29, 2020
Q2 2020
Jun 29, 2020
Q1 2020
Mar 30, 2020
Revenue
101K 101K 179K 179K 158K 158K 155K 196K 196K 196K 197K 204K 204K 205K 204K 251K 250K 148K 150K 211K 204K 198K
Cost of Revenue
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Gross Profit
101K 101K 179K 179K 158K 158K 155K 196K 196K 196K 197K 204K 204K 205K 204K 251K 250K 148K 150K 211K 204K 198K
Operating Income
-2.45M -2.45M -2.02M -2.02M -2.05M -2.05M -1.83M -1.87M -1.78M -2.71M -3.08M -2.57M -2.07M -2.5M -4.03M -3.51M -3.13M -2.17M -3.55M -2.48M -3.83M -4.28M
Interest Income
11K 11K 77K 77K 68.5K 68.5K 127K 106K 111K 162K 363K 44K n/a n/a n/a 110K n/a 293K 21K n/a n/a n/a
Pretax Income
-2.44M -2.44M -1.96M -1.96M -1.98M -1.98M -1.65M -1.76M -1.67M -2.55M -3.02M -2.53M -2.19M -2.43M -4.12M -3.4M -3.22M -1.88M -3.63M -2.58M -3.89M -4.34M
Net Income
-2.44M -2.44M -1.96M -1.96M -1.98M -1.98M -1.65M -1.76M -1.67M -2.39M -2.96M -2.44M -2.43M -2.56M -4.12M -3.4M -3.22M -1.88M -3.63M -2.58M -3.89M -4.34M
Selling & General & Admin
1.03M 1.03M 761K 761K 762.5K 762.5K 722K 762K 624K 847K 826K 741K 822K 754K 1.13M 822K 876K 1.02M 807K 689K 752K 703K
Research & Development
1.52M 1.52M 1.44M 1.44M 1.44M 1.44M 1.27M 1.3M 1.36M 2.06M 2.45M 2.04M 1.45M 1.82M 3.1M 2.94M 2.51M 1.3M 2.9M 2M 3.28M 3.77M
Other Expenses
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Operating Expenses
2.55M 2.55M 2.2M 2.2M 2.21M 2.21M 1.99M 2.06M 1.98M 2.91M 3.28M 2.78M 2.27M 2.58M 4.23M 3.76M 3.38M 2.32M 3.7M 2.69M 4.04M 4.47M
Interest Expense
n/a n/a n/a n/a n/a n/a 14K 3K n/a n/a 16K n/a 121K 64K 315K n/a 86K n/a 139K 96K 62K 66K
Selling & Marketing Expenses
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Cost & Expenses
2.55M 2.55M 2.2M 2.2M 2.21M 2.21M 1.99M 2.06M 1.98M 2.91M 3.28M 2.78M 2.27M 2.58M 4.23M 3.76M 3.38M 2.32M 3.7M 2.69M 4.04M 4.47M
Income Tax Expense
n/a n/a n/a n/a n/a n/a n/a -3.5K -4K -162K -64K -88K 242K 128K n/a -3K -4K -3K n/a -3.5K -3K -3.5K
Shares Outstanding (Basic)
11.38M 11.38M 8.44M 8.44M 6.07M 6.07M 4.95M 4.08M 4.09M 3.93M 2.72M 2.72M 2.72M 2.72M 1.36M 1.83M 1.72M 1.61M 1.55M 1.53M 1.03M 576.51K
Shares Outstanding (Diluted)
11.37M 11.37M 8.44M 8.44M 6.07M 6.07M 4.95M 4.08M 4.08M 3.93M 2.72M 2.72M 2.72M 2.72M 2.22M 1.83M 1.72M 1.61M 1.55M 1.53M 1.03M 671.45K
EPS (Basic)
-0.21 -0.21 -0.24 -0.24 -0.33 -0.33 -0.33 -0.42 -0.42 -0.66 -1.11 -0.93 -0.81 -0.90 -3.03 -1.86 -1.86 -1.17 -2.34 -1.68 -3.78 -7.53
EPS (Diluted)
-0.21 -0.21 -0.24 -0.24 -0.33 -0.33 -0.33 -0.42 -0.42 -0.66 -1.11 -0.93 -0.81 -0.90 -3.03 -1.86 -1.86 -1.17 -2.34 -1.68 -3.78 -7.53
EBITDA
-2.44M -2.44M -2.02M -2.02M -2.05M -2.05M -1.83M -1.86M -1.78M -2.71M -3.08M -2.57M -2.07M -2.37M -4.02M -3.51M -3.13M -2.17M -3.55M -2.48M -3.83M -4.27M
EBIT
-2.45M -2.45M -2.02M -2.02M -2.05M -2.05M -1.83M -1.87M -1.78M -2.71M -3.08M -2.57M -2.07M -2.37M -4.03M -3.51M -3.13M -2.17M -3.49M -2.48M -3.83M -4.28M
Depreciation & Amortization
11.5K 11.5K 3K 3K 500 500 3.75K 3.5K 4K 3.5K 3.5K 3.5K 3K 3.5K 3.5K 3K 4K 3K 3K 3.5K 3K 3.5K

© 2026 bestshares.com. All rights reserved.